BI 1569912
Phase 2
Indication: Major Depressive Disorder (MDD) NR2B NAM
This compound is under investigation, further information will be available soon.
Phase 2
Indication: Major Depressive Disorder (MDD) NR2B NAM
This compound is under investigation, further information will be available soon.